Sensex, Nifty extend rally; Aurobindo, Glenmark, Sun Pharma jump

Epic Update Aurobindo Pharma
Epic Update Aurobindo Pharma

Equity benchmarks as well as broader markets extended rally in noon trade with the Sensex rising over 100 points. Healthcare, FMCG, oil and select infra stocks gained strength.

The 30-share BSE Sensex rose 121.15 points to 27908.77 and the 50-share NSE Nifty climbed 34.10 points to 8562.65.

The broader markets like BSE Midcap and Smallcap indices gained 0.8 percent each as about two shares advanced for every share declining on the exchange.

Aurobindo Pharma, Glenmark and Sun Pharmaceutical gained 2-4 percent intraday after the US health regulator has given approval for antihyperlipidemic drug Rosuvastatin calcium tablets. The approved ANDA, which is bioequivalent and therapeutically equivalent to the reference listed drug product Crestor tablets of IPR Pharmaceuticals Inc, has an estimated market size of USD 6.7 billion for the twelve months ending May 2016, according to IMS.
For more information and best NIFTY FUTURES TIPS Call us ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Connect with our social media sites
Previous
Next Post »